ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 95 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203 | -32.6% | 41,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $301 | +171.2% | 41,000 | +68.7% | 0.00% | – |
| Q1 2023 | $111 | -60.1% | 24,300 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $278 | -99.9% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $233,000 | +18.3% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $197,000 | -53.2% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $421,000 | -13.2% | 24,300 | +10.0% | 0.00% | 0.0% |
| Q4 2021 | $485,000 | -69.2% | 22,100 | +2.8% | 0.00% | -75.0% |
| Q3 2021 | $1,577,000 | +184.1% | 21,500 | +104.8% | 0.00% | +100.0% |
| Q2 2021 | $555,000 | -22.6% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $717,000 | -19.1% | 10,500 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $886,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $46,559,640 | 13.20% |
| Vivo Capital, LLC | 4,220,048 | $20,256,230 | 2.22% |
| Logos Global Management LP | 1,000,000 | $4,800,000 | 0.64% |
| Orbimed Advisors | 2,871,000 | $13,780,800 | 0.29% |
| Redmile Group, LLC | 1,283,289 | $6,159,787 | 0.29% |
| BRAIDWELL LP | 1,249,900 | $5,999,520 | 0.19% |
| Cormorant Asset Management, LP | 612,079 | $2,937,979 | 0.17% |
| Nan Fung Group Holdings Ltd | 41,950 | $201,360 | 0.16% |
| Forefront Analytics, LLC | 13,769 | $66,092 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 35,071 | $168,341 | 0.03% |